bio-europe spring® 2017: biomunex cso defines lead compounds, early r&d plans
Published 7 years ago • 391 plays • Length 6:13Download video MP4
Download video MP3
Similar videos
-
7:00
bio-europe spring® 2017: biomunex ceo on earlier deals for cancer drugs
-
6:13
biomunex cso defines lead compounds, early r&d plans
-
8:00
bio-europe spring® 2017: partnerships are key for rare disease drug discovery and development
-
8:28
bio-europe spring® 2017: shanghai henilus biotech has blockbuster biologics in biosimilar crosshairs
-
8:36
bio-europe spring® 2016: strategic unit at md anderson forges creative alliances
-
4:22
bio-europe spring® 2016: synthetic biologics ceo outlines development plans for lead assets
-
15:12
bioorb air and biopod and more at interzoo 2018
-
12:32
bridge biotherapeutics @ bio international convention 2023
-
21:04
showcase biosurveillance
-
0:31
bio-europe spring 2023
-
15:08
bio-europe spring® 2018: commercializing cell and gene therapies
-
8:34
bio-europe spring® 2017: sinergium provides gateway to latin american vaccine and biologics markets
-
7:07
bio-europe spring® 2016: selexis ceo talks licensing, academic partnerships and biosimilars
-
4:59
bio-europe spring® 2016: lucentis biosimilar to be sold to emerging markets by xbrane biopharma
-
0:24
bio-europe spring 2023
-
11:00
bio-europe spring® 2016: quretech bio explains novel approach to antibiotic development
-
1:04
bio-europe® is where great biotech partnerships begin
-
14:48
bridge biotherapeutics @ bio-europe spring 2022
-
1:53
bio-europe spring® 2018 in amsterdam - biotech, pharma and finance partnering conference
-
1:00
slas europe 2022 innovation avenew: sun bioscience